(Q24245383)

English

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma

scientific article

In more languages

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma (English)

0 references

0 references

Francine M Ducharme

4

object named as

Francine Ducharme

0 references

author name string

Ilana IG Greenstone

1

0 references

Muireann Ni Chroinin

2

0 references

Toby J Lasserson

3

0 references

publication date

19 October 2005

0 references

Cochrane Database of Systematic Reviews

0 references

Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Comparison of fluticasone propionate-salmeterol combination therapy and montelukast in patients who are symptomatic on short-acting beta(2)-agonists alone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Comparison of intramuscular betamethasone and oral prednisone in the prevention of relapse of acute asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Serum potassium levels, CPK-MB and ECG in children suffering asthma treated with beclomethasone or beclomethasone-salmeterol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Potential masking effects of salmeterol on airway inflammation in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

21 January 2018

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol/fluticasone propionate (50/100 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in children with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Models for estimating the number of unpublished studies.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of salmeterol in childhood asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of salmeterol is independent of previously inhaled salbutamol: a clinical controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Nocturnal asthma: effect of treatment with oral sustained-release terbutaline, inhaled budesonide, and the two in combination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood eosinophil numbers and activity during 24 hours: effects of treatment with budesonide and bambuterol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Pilgrim's progress: the effect of salmeterol in older children with chronic severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials: are these your patients?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of treatment with formoterol on bronchoprotection against methacholine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

β2-Adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma☆☆☆★★★

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A high dose of albuterol does not overcome bronchoprotective subsensitivity in asthmatic subjects receiving regular salmeterol or formoterol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: a multicenter, randomized, open-label trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol 12 microg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: a multicenter, randomized, open-label, parallel-group study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of anti-asthmatic drugs on the response to inhaled endotoxin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of salmeterol and salmeterol plus beclomethasone on saliva flow and IgA in patients with moderate-persistent chronic asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, placebo-controlled comparison of the safety and efficacy of salmeterol or beclomethasone for persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of fluticasone propionate 44 μg/salmeterol 21 μg administeredin a hydrofluoroalkane metered-dose inhaleras an initial asthma maintenance treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotriene receptor antagonists in the treatment of asthma: an update

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Airway inflammatory response to ozone in subjects with different asthma severity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Long acting inhaled beta2-agonists: anti-inflammatory effects not evident during treatment of day to day asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of anti-allergic mattress encasings on house dust mite-induced early- and late-airway reactions in asthmatic patients. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Sputum cellular and cytokine responses to inhaled endothelin-1 in asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits of high altitude allergen avoidance in atopic adolescents with moderate to severe asthma, over and above treatment with high dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of fluticasone and salmeterol on airway effects of inhaled organic dust;an in vivo and ex vivo study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of inhaled salmeterol to inhaled corticosteroids in patients with poorly controlled nocturnal asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 microg twice daily and budesonide 800 microg twice daily in the treatment of adults and adolescents with asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison between formoterol 12 microg b.i.d. and on-demand salbutamol in moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A cost-effectiveness study comparing the as-needed use of formoterol (Oxis) and terbutaline (Bricanyl) in patients with moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting bronchodilators in premenstrual exacerbation of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

The inflammatory marker serum eosinophil cationic protein (ECP) compared with PEF as a tool to decide inhaled corticosteroid dose in asthmatic patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness of eformoterol Turbohaler versus salmeterol Accuhaler in children with symptomatic asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of regular inhaled formoterol and budesonide on preformed Th-2 cytokines in mild asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Possibilities of formoterol to enhance the peripheral lung deposition of the inhaled liposome corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patien

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of salmeterol to fluticasone propionate treatment in moderate-to-severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of salmeterol xinafoate on lung mucociliary clearance in patients with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort Turbuhaler) for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of salmeterol (50 microgram) and fluticasone (250 microgram) in a single inhaler device (diskus) in patients with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Miflonide/Foradil via Aerolizer compared with other anti-inflammatory and anti-obstructive therapeutic regimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of beta-adrenergic agonists on mucociliary clearance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced synergy between fluticasone propionate and salmeterol inhaled from a single inhaler versus separate inhalers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial of nebulized magnesium sulfate in addition to albuterol in the treatment of acute mild-to-moderate asthma exacerbations in adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-density areas on high-resolution computed tomograms in chronic pediatric asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Antitussive effect of the leukotriene receptor antagonist zafirlukast in subjects with cough-variant asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved ability to perform strenuous activities after treatment with fluticasone propionate/salmeterol combination in patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Metering performance of several metered-dose inhalers with different spacers/holding chambers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Continuing patient care with metered-dose inhalers.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Need for theophylline in severe steroid-requiring asthmatics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol in two different doses in the treatment of nocturnal bronchial asthma poorly controlled by other therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol compared with slow-release terbutaline in nocturnal asthma. A multicenter, randomized, double-blind, double-dummy, sequential clinical trial. French Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of budesonide on the response to inhaled terbutaline in children with mild asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term effects of budesonide, nedocromil sodium and salmeterol on bronchial hyperresponsiveness in childhood asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised controlled trial of short term growth and collagen turnover in asthmatics treated with inhaled formoterol and budesonide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Bronchodilator treatment and deaths from asthma: case-control study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol in paediatric asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Marginal benefits of adding formoterol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Leukotriene receptor antagonists as add-on therapy for adults with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in methacholine induced bronchoconstriction with the long acting beta 2 agonist salmeterol in mild to moderate asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of an asthma quality of life diary in a clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Adult Asthma Consensus Guidelines update 2003.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of an inhaled corticosteroid (triamcinolone acetonide) to a long-acting bronchodilator (salmeterol), the combination, and placebo in mild-moderate adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A health-related quality-of-life comparison of formoterol (Oxis) Turbuhaler plus budesonide (Pulmicort) Turbuhaler with budesonide Turbuhaler alone and noncorticosteroid treatment in asthma: a randomized clinical study in Russia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term circadian effects of salmeterol in asthmatic children treated with inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled, crossover comparison of salmeterol and salbutamol in patients with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone propionate, salmeterol xinafoate, and their combination in the treatment of nocturnal asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of formoterol by Turbuhaler as reliever medication compared with terbutaline in moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of salmeterol on mucosal inflammation in asthma: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of salmeterol compared with beclomethasone on allergen-induced asthmatic and inflammatory responses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A dose-response study with formoterol Turbuhaler as maintenance therapy in asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of addition of inhaled salmeterol to the treatment of moderate-to-severe asthmatics uncontrolled on high-dose inhaled steroids. European Respiratory Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone versus salmeterol/low-dose fluticasone for long-term asthma control

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol, a new long-acting beta 2 agonist, inhaled twice daily, in stable asthmatic subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled Salmeterol and Albuterol in Asthmatic Patients Receiving High-dose Inhaled Corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-acting inhaled beta2-agonists in asthma therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

The 1997 Asthma Management Guidelines and therapeutic issues relating to the treatment of asthma. National Heart, Lung, and Blood Institute

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled beclomethasone dipropionate reverts tolerance to the protective effect of salmeterol on allergen challenge

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled study to evaluate the role of salmeterol in the in-hospital management of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Additive effects of salmeterol and fluticasone or theophylline in COPD

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness and safety of salmeterol in nonspecialist practice settings

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of salmeterol and formoterol in patients with severe asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta(2)-agonists: déjà vu all over again: the second-generation controversy.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Airway tissue mast cells in persistent asthma: predictor of treatment failure when patients discontinue inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Budesonide/formoterol for the treatment of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol. A review of its pharmacological properties and clinical efficacy in the management of children with asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Airmax: a multi-dose dry powder inhaler

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of an economic model to assess the cost effectiveness of asthma management strategies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol/Fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Formoterol delivered by Turbuhaler: in pediatric asthma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of a common effect parameter from sparse follow-up data

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005533

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD005533

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24245383&oldid=1475291499"